NFKB1 and head and neck squamous cell carcinoma: A preclinical study indicated that cisplatin-resistant HNSCC cell lines (HONE1, HNE1, and CNE2) highly express BST2, and BST2 can prevent cell apoptosis via the NF-κB pathway.